The global drug eluting stent (DES) market size was valued at USD 5.71 billion in 2018 and is projected to reach USD 13.52 billion by 2032, exhibiting a CAGR of 6.3% during the forecast period. North America dominated the drug eluting stent market with a 30.82% share in 2018, driven by advanced healthcare infrastructure, high prevalence of cardiovascular diseases, and strong adoption of innovative stent technologies.